Benefits
Memory and learning
Standardized Bacopa monnieri extracts have improved memory and learning measures in randomized trials, with any benefit building gradually over several weeks rather than after a single dose. The most brand-relevant evidence is a 12-week trial of the same CDRI 08 extract (sold as Keenmind and Synapsa) that reported gains in learning and memory over the weeks.
Cognitive performance
Trials of standardized Bacopa extracts report modest gains in information processing and recall in healthy adults, which is why Bacopa is described as a slow, cumulative nootropic rather than a same-day one. Results are not uniform across studies, and none of the cited evidence is Synapsa-specific.
Calm focus
Bacopa is traditionally used as a calming, adaptogenic herb, and users often describe a settled rather than stimulated kind of focus. This reflects traditional use and user reports; it is not an outcome measured in the research cited on this page.
Mechanism of action
Bacoside neuroprotection
In laboratory and animal work, bacosides act as antioxidants in brain tissue, support synaptic communication, and promote dendritic growth. These are proposed mechanisms for the memory findings, not effects measured directly in humans.
Neurotransmitter modulation
Bacopa influences acetylcholine and serotonin signaling involved in learning and mood.
Clinical trials
Systematic review and network meta-analysis comparing Bacopa monnieri and Ginkgo biloba across cognitive outcomes. This is evidence for standardized Bacopa extracts as a class, not a trial of Synapsa itself. (Tiemtad et al. 2026, Phytomedicine)
Adults across the Bacopa and Ginkgo trials pooled by the review.
This is a pooled analysis of previously published Bacopa and Ginkgo trials rather than a single new study. It supports standardized Bacopa extracts as a class, with any cognitive effect building over weeks of daily use rather than acutely, and it does not establish a result for the Synapsa extract specifically.